Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023

The global cell line development market size is expected to reach USD 10.09 billion by 2030 and is expected to expand at a CAGR of 9.81% from 2023 to 2030, according to a new report by Grand View Research, Inc.. One of the primary factors driving the expansion of the cell line development (CLD) market is an increase in vaccine production around the world, especially after the spread of coronavirus. Rising use of new healthcare technology and rising cancer incidences, create more attractive and lucrative growth prospects for the CLD market. The expansion and growth of the biologics sector will also be a major CLD market development determinant.

The increasing product launches of technologically improved products for CLD are likely to drive market expansion. For example, CYTENA, a BICO subsidiary, introduced a new platform for entirely automated stable cell line development in October 2021. To enable cost-effective and better laboratory automation, the system integrates CYTENA's best-in-class liquid handling information with its existing established single-cell dispensing technology. BICO's Bio Convergence agenda is advanced through the broadening of accessibility to the advancement of next-generation medical services such as antibody treatments, gene therapies, and biosimilar production.

Moreover, according to the July 2021 Pharma Manufacturing Updates, approximately 20 drugs, comprising a few blockbusters including Novartis' Entresto & Biogen's Spinraza, are going to have their patents scheduled to expire in 2023. The expiration of branded pharmaceuticals has resulted in the creation of biosimilars. As a result, the requirement for cell line development is increasing. Thus, it will drive the market growth.

Furthermore, the growing company strategies such as collaboration, expansion, and acquisitions are also driving the market growth. For instance, ProBioGen and Granite Bio collaborated in July 2022 to provide GMP manufacturing & cell line development solutions and support Granite Bio's mAb pipeline development. Similarly, in June 2022, FUJIFILM Corporation announced a USD 1.6 billion investment to improve and expand the cell culture production capabilities of FUJIFILM Diosynth Biotechnologies. Furthermore, in October 2022, Cytiva, acquired CEVEC Pharmaceuticals, a prominent German producer of advanced CLD & viral vector manufacturing technology. Through this development, CEVEC will help Cytiva maintain its leadership position in biomanufacturing technologies.

However, the high capital expenses and expenditure needed to construct research and development capabilities would be a barrier to the cell line development industry.

Cell Line Development Market Report Highlights:

By product, the reagents and media segment accounted for the largest share of 43.78% in 2022. Due to their cost-intensive nature and frequent use in the manufacturing of biologics, these items account for the biggest revenue share.
By source, the mammalian cell line segment accounted for the largest share of 72.62% in 2022.Its rapid expansion is a result of the effective manufacture of biopharmaceuticals by mammalian cell lines, as they are able to express complex proteins that are identical to those found in humans.
By type of cell line, the recombinant cell lines companies segment accounted for the largest share of 31.79% in 2022 due to its widespread application in biologics manufacturing processes, gene activation, including protein interactions.
By application, the bioproduction segment held the largest market share of 46.30% in 2022. Factors such as increased in-vitro research activities, product safety and efficacy concerns, the demand for biosimilars, and rising demand for cellular therapies are driving the bioproduction industry.
North America held the larger share of 39.22% in 2022 due to the presence of constant technological improvements followed by new discoveries sparking the adoption of newer processes for bioproduction. The presence of rigorous activities carried out by research businesses operating in this region, such as Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, and American Type Culture Collection (ATCC), which provide high-quality CLD services, is contributing to growth.
A few of the key market players of the market include Thermo Fisher Scientific Inc., Corning Inc., Lonza, Creative BioLabs., WuXi PharmaTech, Sartorius AG, Merck KGaA, Advanced Instruments, Berkeley Lights, Danaher among others.

Product Code: 978-1-68038-481-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Information analysis
- 1.2.2. Market formulation & data visualization
- 1.2.3. Data validation & publishing
1.3. Information Procurement
- 1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
- 1.7.1. Objective 1
- 1.7.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Patent expiration of blockbuster biologics
- 3.3.2. Rising demand for monoclonal antibodies
- 3.3.3. Increasing vaccine production
- 3.3.4. Technological advancement for the cell line development
- 3.3.5. Increasing prevalence of cancer
- 3.3.6. Growing R&D investments in biotechnology sector
3.4. Market Restraint Analysis
- 3.4.1. Presence of complicated regulatory framework
3.5. Business Environment Analysis
- 3.5.1. PESTEL Analysis
- 3.5.2. Porter's Five Forces Analysis
- 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product & Services Business Analysis

4.1. Global cell line development market: Product & Services Movement Analysis
4.2. Reagents and media
- 4.2.1. Reagents and media Market, 2018 - 2030 (USD Million)
4.3. Equipment
- 4.3.1. Equipment Market, 2018 - 2030 (USD Million)
- 4.3.2. Automated Systems
  - 4.3.2.1. Automated Systems Market, 2018 - 2030 (USD Million)
- 4.3.3. Centrifuges
  - 4.3.3.1. Centrifuges Market, 2018 - 2030 (USD Million)
- 4.3.4. Bioreactors
  - 4.3.4.1. Bioreactors Market, 2018 - 2030 (USD Million)
- 4.3.5. Storage equipment
  - 4.3.5.1. Storage equipment Market, 2018 - 2030 (USD Million)
- 4.3.6. Others
  - 4.3.6.1. Others Market, 2018 - 2030 (USD Million)
4.4. Accessories and consumables
- 4.4.1. Accessories and consumables Market, 2018 - 2030 (USD Million)
4.5. Services
- 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Source Business Analysis

5.1. Global cell line development market: Source Movement Analysis
5.2. Mammalian cell line
- 5.2.1. Mammalian cell line Market, 2018 - 2030 (USD Million)
5.3. Non-mammalian cell line
- 5.3.1. Non-mammalian cell line Market, 2018 - 2030 (USD Million)
- 5.3.2. Insects
  - 5.3.2.1. Insects Market, 2018 - 2030 (USD Million)
- 5.3.3. Amphibians
  - 5.3.3.1. Amphibians Market, 2018 - 2030 (USD Million)

Chapter 6. Type of Cell Lines Business Analysis

6.1. Global cell line development market: Type of Cell Lines Movement Analysis
6.2. Recombinant cell lines
- 6.2.1. Recombinant cell lines Market, 2018 - 2030 (USD Million)
6.3. Hybridomas
- 6.3.1. Hybridomas Market, 2018 - 2030 (USD Million)
6.4. Continuous cell lines
- 6.4.1. Continuous cell lines Market, 2018 - 2030 (USD Million)
6.5. Primary cell lines
- 6.5.1. Primary cell lines Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

7.1. Global cell line development market: Application Movement Analysis
7.2. Bioproduction
- 7.2.1. Bioproduction Market, 2018 - 2030 (USD Million)
7.3. Drug discovery
- 7.3.1. Drug discovery Market, 2018 - 2030 (USD Million)
7.4. Toxicity testing
- 7.4.1. Toxicity testing Market, 2018 - 2030 (USD Million)
7.5. Tissue engineering
- 7.5.1. Tissue engineering Market, 2018 - 2030 (USD Million)
7.6. Others
- 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

8.1. Global Cell line development market Share By Region, 2022 & 2030
8.2. North America
- 8.2.1. North America cell line development market, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. Key Country Dynamics
  - 8.2.2.2. Competitive Scenario
  - 8.2.2.3. Regulatory Framework
  - 8.2.2.4. Target Disease Prevalence
  - 8.2.2.5. U.S. cell line development market, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Key Country Dynamics
  - 8.2.3.2. Competitive Scenario
  - 8.2.3.3. Regulatory Framework
  - 8.2.3.4. Target Disease Prevalence
  - 8.2.3.5. Canada cell line development market, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Cell line development market, 2018 - 2030 (USD Million)
- 8.3.2. Germany
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. Target Disease Prevalence
  - 8.3.2.5. Germany cell line development market, 2018 - 2030 (USD Million)
- 8.3.3. UK
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Target Disease Prevalence
  - 8.3.3.5. UK cell line development market, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Target Disease Prevalence
  - 8.3.4.5. France cell line development market, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Key Country Dynamics
  - 8.3.5.2. Competitive Scenario
  - 8.3.5.3. Regulatory Framework
  - 8.3.5.4. Target Disease Prevalence
  - 8.3.5.5. Italy cell line development market, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Key Country Dynamics
  - 8.3.6.2. Competitive Scenario
  - 8.3.6.3. Regulatory Framework
  - 8.3.6.4. Target Disease Prevalence
  - 8.3.6.5. Spain cell line development market, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Key Country Dynamics
  - 8.3.7.2. Competitive Scenario
  - 8.3.7.3. Regulatory Framework
  - 8.3.7.4. Target Disease Prevalence
  - 8.3.7.5. Denmark cell line development market, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Key Country Dynamics
  - 8.3.8.2. Competitive Scenario
  - 8.3.8.3. Regulatory Framework
  - 8.3.8.4. Target Disease Prevalence
  - 8.3.8.5. Sweden cell line development market, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Key Country Dynamics
  - 8.3.9.2. Competitive Scenario
  - 8.3.9.3. Regulatory Framework
  - 8.3.9.4. Target Disease Prevalence
  - 8.3.9.5. Norway cell line development market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific cell line development market, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. Target Disease Prevalence
  - 8.4.2.5. Japan cell line development market, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Target Disease Prevalence
  - 8.4.3.5. China cell line development market, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. Target Disease Prevalence
  - 8.4.4.5. India cell line development market, 2018 - 2030 (USD Million)
- 8.4.5. South Korea
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Target Disease Prevalence
  - 8.4.5.5. South Korea cell line development market, 2018 - 2030 (USD Million)
- 8.4.6. Australia
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Target Disease Prevalence
  - 8.4.6.5. Australia cell line development market, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Target Disease Prevalence
  - 8.4.7.5. Thailand cell line development market, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America cell line development market, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Target Disease Prevalence
  - 8.5.2.5. Brazil cell line development market, 2018 - 2030 (USD Million)
- 8.5.3. Mexico
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Target Disease Prevalence
  - 8.5.3.5. Mexico cell line development market, 2018 - 2030 (USD Million)
- 8.5.4. Argentina
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. Target Disease Prevalence
  - 8.5.4.5. Argentina cell line development market, 2018 - 2030 (USD Million)
8.6. MEA
- 8.6.1. MEA cell line development market, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Target Disease Prevalence
  - 8.6.2.5. South Africa cell line development market, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Target Disease Prevalence
  - 8.6.3.5. Saudi Arabia cell line development market, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Target Disease Prevalence
  - 8.6.4.5. UAE cell line development market, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Target Disease Prevalence
  - 8.6.5.5. Kuwait cell line development market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market/PositionShare Analysis, 2022
9.4. Company Profiles/Listing
- 9.4.1. Thermo Fisher Scientific Inc.
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Danaher
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. Merck KGaA
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. Sartorius AG
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Lonza
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. WuXi PharmaTech
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Advanced Instruments
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Berkeley Lights
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Creative BioLabs
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Corning Inc.
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives

Product Code: 978-1-68038-481-9

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 4 Global Cell line development market by Source, 2018 - 2030 (USD Million)
Table 5 Global Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 6 Global Cell line development market by Application, 2018 - 2030 (USD Million)
Table 7 North America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 8 North America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 9 North America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 10 North America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 11 North America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 12 U.S. Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 13 U.S. Cell line development market by Source, 2018 - 2030 (USD Million)
Table 14 U.S. Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 15 U.S. Cell line development market by Application, 2018 - 2030 (USD Million)
Table 16 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 17 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 18 Canada Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 19 Canada Cell line development market by Application, 2018 - 2030 (USD Million)
Table 20 Europe Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 21 Europe Cell line development market by Source, 2018 - 2030 (USD Million)
Table 22 Europe Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 23 Europe Cell line development market by Application, 2018 - 2030 (USD Million)
Table 24 Europe Cell line development market by Country, 2018 - 2030 (USD Million)
Table 25 UK Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 26 UK Cell line development market by Source, 2018 - 2030 (USD Million)
Table 27 UK Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 28 UK Cell line development market by Application, 2018 - 2030 (USD Million)
Table 29 Germany Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 30 Germany Cell line development market by Source, 2018 - 2030 (USD Million)
Table 31 Germany Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 32 Germany Cell line development market by Application, 2018 - 2030 (USD Million)
Table 33 France Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 34 France Cell line development market by Source, 2018 - 2030 (USD Million)
Table 35 France Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 36 France Cell line development market by Application, 2018 - 2030 (USD Million)
Table 37 Italy Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 38 Italy Cell line development market by Source, 2018 - 2030 (USD Million)
Table 39 Italy Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 40 Italy Cell line development market by Application, 2018 - 2030 (USD Million)
Table 41 Spain Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 42 Spain Cell line development market by Source, 2018 - 2030 (USD Million)
Table 43 Spain Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 44 Spain Cell line development market by Application, 2018 - 2030 (USD Million)
Table 45 Denmark Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 46 Denmark Cell line development market by Source, 2018 - 2030 (USD Million)
Table 47 Denmark Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 48 Denmark Cell line development market by Application, 2018 - 2030 (USD Million)
Table 49 Sweden Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 50 Sweden Cell line development market by Source, 2018 - 2030 (USD Million)
Table 51 Sweden Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 52 Sweden Cell line development market by Application, 2018 - 2030 (USD Million)
Table 53 Norway Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 54 Norway Cell line development market by Source, 2018 - 2030 (USD Million)
Table 55 Norway Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 56 Norway Cell line development market by Application, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Cell line development market by Source, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Cell line development market by Application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Cell line development market by Country, 2018 - 2030 (USD Million)
Table 62 China Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 63 China Cell line development market by Source, 2018 - 2030 (USD Million)
Table 64 China Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 65 China Cell line development market by Application, 2018 - 2030 (USD Million)
Table 66 Japan Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 67 Japan Cell line development market by Source, 2018 - 2030 (USD Million)
Table 68 Japan Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 69 Japan Cell line development market by Application, 2018 - 2030 (USD Million)
Table 70 India Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 71 India Cell line development market by Source, 2018 - 2030 (USD Million)
Table 72 India Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 73 India Cell line development market by Application, 2018 - 2030 (USD Million)
Table 74 South Korea Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 75 South Korea Cell line development market by Source, 2018 - 2030 (USD Million)
Table 76 South Korea Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 77 South Korea Cell line development market by Application, 2018 - 2030 (USD Million)
Table 78 Australia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 79 Australia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 80 Australia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 81 Australia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 82 Thailand Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 83 Thailand Cell line development market by Source, 2018 - 2030 (USD Million)
Table 84 Thailand Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 85 Thailand Cell line development market by Application, 2018 - 2030 (USD Million)
Table 86 Latin America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 87 Latin America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 88 Latin America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 89 Latin America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 90 Latin America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 91 Brazil Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 92 Brazil Cell line development market by Source, 2018 - 2030 (USD Million)
Table 93 Brazil Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 94 Brazil Cell line development market by Application, 2018 - 2030 (USD Million)
Table 95 Mexico Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 96 Mexico Cell line development market by Source, 2018 - 2030 (USD Million)
Table 97 Mexico Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 98 Mexico Cell line development market by Application, 2018 - 2030 (USD Million)
Table 99 Argentina Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 100 Argentina Cell line development market by Source, 2018 - 2030 (USD Million)
Table 101 Argentina Cell line development market by Type of Cell Liner, 2018 - 2030 (USD Million)
Table 102 Argentina Cell line development market by Application, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Cell line development market by Country, 2018 - 2030 (USD Million)
Table 108 South Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 109 South Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 110 South Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 111 South Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 116 UAE Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 117 UAE Cell line development market by Source, 2018 - 2030 (USD Million)
Table 118 UAE Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 119 UAE Cell line development market by Application, 2018 - 2030 (USD Million)
Table 120 Kuwait Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 121 Kuwait Cell line development market by Source, 2018 - 2030 (USD Million)
Table 122 Kuwait Cell line development market By Type of Cell Line, 2018 - 2030 (USD Million)
Table 123 Kuwait Cell line development market by Application, 2018 - 2030 (USD Million)
Table 124 Participant's Overview
Table 125 Financial Performance
Table 126 Key Companies Undergoing Expansions
Table 127 Key Companies Undergoing Acquisitions
Table 128 Key Companies Undergoing Collaborations
Table 129 Key Companies Launching New Products/Services
Table 130 Key Companies Undergoing Partnerships
Table 131 Key Companies Undertaking Other Strategies

List of Figures

Fig. 1 Market Others process
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter's analysis
Fig. 14 SWOT analysis
Fig. 15 Global cell line development market: Product & services outlook and key takeaways
Fig. 16 Global cell line development market: Product & services movement analysis
Fig. 17 Global reagents and media market, 2018 - 2030 (USD Million)
Fig. 18 Global equipment market, 2018 - 2030 (USD Million)
Fig. 19 Global Automated Systems market, 2018 - 2030 (USD Million)
Fig. 20 Global centrifuges market, 2018 - 2030 (USD Million)
Fig. 21 Global bioreactors market, 2018 - 2030 (USD Million)
Fig. 22 Global storage equipment market, 2018 - 2030 (USD Million)
Fig. 23 Global Others market, 2018 - 2030 (USD Million)
Fig. 24 Global Accessories and consumables market, 2018 - 2030 (USD Million)
Fig. 25 Global cell line development market: Source outlook and key takeaways
Fig. 26 Global cell line development market: Source movement analysis
Fig. 27 Global mammalian cell line market, 2018 - 2030 (USD Million)
Fig. 28 Global non-mammalian cell line market, 2018 - 2030 (USD Million)
Fig. 29 Global insects market, 2018 - 2030 (USD Million)
Fig. 30 Global amphibians market, 2018 - 2030 (USD Million)
Fig. 31 Global cell line development market: Type of cell line outlook and key takeaways
Fig. 32 Global cell line development market: Type of cell line movement analysis
Fig. 33 Global recombinant cell lines market, 2018 - 2030 (USD Million)
Fig. 34 Global hybridomas market, 2018 - 2030 (USD Million)
Fig. 35 Global continuous cell lines market, 2018 - 2030 (USD Million)
Fig. 36 Global primary cell lines market, 2018 - 2030 (USD Million)
Fig. 37 Global cell line development market: Application outlook and key takeaways
Fig. 38 Global cell line development market: Application movement analysis
Fig. 39 Global bioproduction market, 2018 - 2030 (USD Million)
Fig. 40 Global drug discovery market, 2018 - 2030 (USD Million)
Fig. 41 Global toxicity testing market, 2018 - 2030 (USD Million)
Fig. 42 Global tissue engineering market, 2018 - 2030 (USD Million)
Fig. 43 Global Others market, 2018 - 2030 (USD Million)
Fig. 44 Global cell line development market: Regional outlook and key takeaways
Fig. 45 North America cell line development market, 2018 - 2030 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. cell line development market, 2018 - 2030 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada cell line development market, 2018 - 2030 (USD Million)
Fig. 50 Europe cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany key country dynamics
Fig. 52 Germany cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France key country dynamics
Fig. 54 France cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 UK key country dynamics
Fig. 56 UK cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Asia-Pacific cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 China key country dynamics
Fig. 69 China cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 India key country dynamics
Fig. 71 India cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 South Korea key country dynamics
Fig. 73 South Korea cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Japan key country dynamics
Fig. 75 Japan cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Australia key country dynamics
Fig. 77 Australia cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Thailand key country dynamics
Fig. 79 Thailand cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Latin America cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Mexico key country dynamics
Fig. 84 Mexico cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 MEA cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Market participant categorization
Fig. 97 Cell line development market share analysis, 2022
Fig. 98 Strategy framework

Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Cell Line Development Market Growth & Trends:

Cell Line Development Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Product & Services Business Analysis

Chapter 5. Source Business Analysis

Chapter 6. Type of Cell Lines Business Analysis

Chapter 7. Application Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures